Iain was appointed to the Board in November 2007 and is currently serving as Chairman.
Iain is an experienced private consultant, investor and nonexecutive director (both listed and unlisted public companies). He has considerable practical and operational experience gained from a successful financial career spanning 35 years in a range of industries including auditing, resources, manufacturing and latterly healthcare in Australia, Britain and the USA. He started his career at Arthur Andersen & Co in London. Before establishing himself as a consultant/advisor and joining a number of boards as a non‑executive director, Iain held a range of senior financial and general management positions in Woodside Petroleum Ltd, Santos Ltd, Pilkington plc, F.H. Faulding & Co Ltd and Clinuvel Pharmaceuticals Limited.
Iain is a Non‑Executive Director of ASX listed companies Medical Developments International Ltd (ASX:MVP), Vision Group Holdings Ltd (ASX:VGH) and Chairman of Avexa Limited (ASX:AVX).
Lee was previously a partner in a premier mid‑tier law firm in their corporate group. He remains a qualified solicitor practising principally in corporate and commercial law advising on corporate and securities regulation, capital raisings, formulation and implementation of mergers and acquisitions, corporate governance and secretarial matters.
Matt Morgan is the Principal of Millers Point Company, a firm which provides strategic and transactional advice to emerging companies. Matt is a former venture capitalist at QIC an institutional fund manager. He is an experienced executive in private equity funded portfolio companies with specific experience in corporate turnarounds. Matt is the co founder and a non executive director of Diversa Ltd and a non executive director of Leaf Resources Ltd. He is Australia’s first Kauffman Fellow and holds an MBA, BCom and BAppSc.